US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 17.090
  • -0.120-0.70%
Close Dec 20 16:00 ET
  • 17.090
  • 0.0000.00%
Post 16:20 ET
301.04MMarket Cap63.30P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
96.58%55.31M
37.03%36.84M
13.29%29.53M
-2.79%116.88M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
-19.43%120.24M
151.25%51.28M
Operating revenue
83.64%72.7M
43.64%52.37M
18.11%41.96M
5.00%159.65M
-21.19%48.07M
31.10%39.59M
22.27%36.46M
112.27%35.52M
-9.18%152.05M
58.08%61M
Cost of revenue
532.97%8.03M
161.12%2.81M
107.27%2.03M
306.52%7.11M
1,008.19%3.79M
407.20%1.27M
3.76%1.08M
707.44%977K
61.50%1.75M
-29.77%342K
Gross profit
75.99%47.28M
31.86%34.03M
9.63%27.51M
-7.36%109.77M
-37.17%32M
21.24%26.87M
-10.33%25.81M
51.04%25.09M
-20.02%118.49M
155.68%50.94M
Operating expense
6.05%33.23M
8.07%33.59M
-8.84%34.48M
-24.58%130.26M
-36.82%30.04M
-22.76%31.33M
-25.56%31.08M
-11.79%37.82M
9.93%172.72M
25.70%47.54M
Selling and administrative expenses
8.80%27.04M
6.62%28.05M
2.60%28.45M
-5.97%105.74M
-16.54%26.85M
-4.02%24.86M
-2.50%26.31M
1.20%27.73M
22.37%112.45M
31.23%32.17M
Research and development costs
-4.53%6.18M
16.09%5.54M
-40.27%6.03M
-59.31%24.52M
-79.26%3.19M
-55.85%6.48M
-67.68%4.77M
-34.80%10.09M
-7.61%60.27M
15.49%15.37M
Operating profit
414.80%14.06M
108.49%447K
45.26%-6.97M
62.21%-20.49M
-42.16%1.97M
75.74%-4.47M
59.38%-5.27M
51.54%-12.73M
-504.23%-54.23M
118.99%3.4M
Net non-operating interest income expense
-33.25%-1.64M
-10.80%-1.48M
-57.95%-1.28M
-52.17%-4.6M
-81.27%-1.23M
-93.53%-1.23M
-152.94%-1.33M
31.50%-811K
37.19%-3.02M
47.16%-678K
Non-operating interest income
-36.76%425K
4.35%552K
50.89%593K
232.16%2.27M
58.04%678K
250.00%672K
1,159.52%529K
1,771.43%393K
1,355.32%684K
2,581.25%429K
Non-operating interest expense
8.48%2.06M
8.97%2.03M
55.65%1.87M
85.38%6.87M
72.27%1.91M
129.90%1.9M
227.24%1.86M
-0.08%1.2M
-23.72%3.71M
-14.78%1.11M
Other net income (expense)
62.51%-1.32M
Special income (charges)
----
----
----
--0
----
----
----
----
62.51%-1.32M
----
-Less：Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
-62.51%1.32M
----
Income before tax
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-238.40%-58.57M
106.17%1.4M
Income tax
0
0
Net income
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
Net income continuous Operations
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
Minority interest income
Net income attributable to the parent company
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
Basic earnings per share
315.15%0.71
84.21%-0.06
37.50%-0.5
58.82%-1.4
-10.00%0.09
70.00%-0.33
52.50%-0.38
50.00%-0.8
-209.09%-3.4
107.69%0.1
Diluted earnings per share
312.12%0.7
84.21%-0.06
37.50%-0.5
58.82%-1.4
-10.00%0.09
70.00%-0.33
52.50%-0.38
50.00%-0.8
-209.09%-3.4
107.69%0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 96.58%55.31M37.03%36.84M13.29%29.53M-2.79%116.88M-30.20%35.79M25.54%28.13M-9.84%26.89M55.78%26.07M-19.43%120.24M151.25%51.28M
Operating revenue 83.64%72.7M43.64%52.37M18.11%41.96M5.00%159.65M-21.19%48.07M31.10%39.59M22.27%36.46M112.27%35.52M-9.18%152.05M58.08%61M
Cost of revenue 532.97%8.03M161.12%2.81M107.27%2.03M306.52%7.11M1,008.19%3.79M407.20%1.27M3.76%1.08M707.44%977K61.50%1.75M-29.77%342K
Gross profit 75.99%47.28M31.86%34.03M9.63%27.51M-7.36%109.77M-37.17%32M21.24%26.87M-10.33%25.81M51.04%25.09M-20.02%118.49M155.68%50.94M
Operating expense 6.05%33.23M8.07%33.59M-8.84%34.48M-24.58%130.26M-36.82%30.04M-22.76%31.33M-25.56%31.08M-11.79%37.82M9.93%172.72M25.70%47.54M
Selling and administrative expenses 8.80%27.04M6.62%28.05M2.60%28.45M-5.97%105.74M-16.54%26.85M-4.02%24.86M-2.50%26.31M1.20%27.73M22.37%112.45M31.23%32.17M
Research and development costs -4.53%6.18M16.09%5.54M-40.27%6.03M-59.31%24.52M-79.26%3.19M-55.85%6.48M-67.68%4.77M-34.80%10.09M-7.61%60.27M15.49%15.37M
Operating profit 414.80%14.06M108.49%447K45.26%-6.97M62.21%-20.49M-42.16%1.97M75.74%-4.47M59.38%-5.27M51.54%-12.73M-504.23%-54.23M118.99%3.4M
Net non-operating interest income expense -33.25%-1.64M-10.80%-1.48M-57.95%-1.28M-52.17%-4.6M-81.27%-1.23M-93.53%-1.23M-152.94%-1.33M31.50%-811K37.19%-3.02M47.16%-678K
Non-operating interest income -36.76%425K4.35%552K50.89%593K232.16%2.27M58.04%678K250.00%672K1,159.52%529K1,771.43%393K1,355.32%684K2,581.25%429K
Non-operating interest expense 8.48%2.06M8.97%2.03M55.65%1.87M85.38%6.87M72.27%1.91M129.90%1.9M227.24%1.86M-0.08%1.2M-23.72%3.71M-14.78%1.11M
Other net income (expense) 62.51%-1.32M
Special income (charges) --------------0----------------62.51%-1.32M----
-Less：Restructuring and merger&acquisition --------------0-----------------62.51%1.32M----
Income before tax 318.22%12.42M84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-238.40%-58.57M106.17%1.4M
Income tax 00
Net income 318.22%12.42M84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M
Net income continuous Operations 318.22%12.42M84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M
Minority interest income
Net income attributable to the parent company 318.22%12.42M84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 318.22%12.42M84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M
Basic earnings per share 315.15%0.7184.21%-0.0637.50%-0.558.82%-1.4-10.00%0.0970.00%-0.3352.50%-0.3850.00%-0.8-209.09%-3.4107.69%0.1
Diluted earnings per share 312.12%0.784.21%-0.0637.50%-0.558.82%-1.4-10.00%0.0970.00%-0.3352.50%-0.3850.00%-0.8-209.09%-3.4107.69%0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data